Affiliation:
1. Toxicological Information Center, Department of Occupational Medicine, First Faculty of Medicine Charles University and General University Hospital Prague Czech Republic
2. Institute of Pharmacology, First Faculty of Medicine Charles University and General University Hospital Prague Czech Republic
3. J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences Prague Czech Republic
Abstract
AbstractDimetindene is a sedating antihistamine indicated for the symptomatic treatment of allergic conditions. Dimetindene is marketed among others under the trade name Fenistil (oral solution). Toxicity data are limited, and there is no consensus on the dose at which children require hospitalization. Objective is to determine the potentially toxic dose in children. Data in children with age up to 15 years were obtained from hospital discharge reports. Of 139 paediatric hospital discharge reports, 23 cases (16.5%) were excluded because of uncertain ingestion. In 116 children (46 boys and 70 girls, mean age 2 years and 9 months ± 1 year and 1 month), the majority of children developed no symptoms (87 children, 75%, mean age 3 years±1 year) and the remaining 29 children (25%, mean age 2 years and 11 months ± 1 year and 3 months) developed only mild and spontaneously resolving symptoms of poisoning after a dose of 0.82 ± 0.32 mg/kg b.w. (range 0.26–1.82 mg/kg). In 98% of all cases, hospitalized children were observed for a maximum 24 h, and their condition did not require specific treatment. In conclusion, the prognosis for accidental dimetindene poisoning in children appears to be good and the minimum toxic dose has been determined to be 0.5 mg/kg b.w.
Reference15 articles.
1. Histamine pharmacology: from Sir Henry Dale to the 21st century
2. Summary of product characteristics. Fenistil 1mg/ml por gtt sol 1x20ml (available online:https://prehledy.sukl.cz/prehled_leciv.html#/detail-reg/0173500) [cit. 2023‐6‐12]
3. Medication errors—an enduring problem for children and elderly patients